UniProt ID | AK17A_HUMAN | |
---|---|---|
UniProt AC | Q02040 | |
Protein Name | A-kinase anchor protein 17A | |
Gene Name | AKAP17A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 695 | |
Subcellular Localization | Nucleus speckle . | |
Protein Description | Splice factor regulating alternative splice site selection for certain mRNA precursors. Mediates regulation of pre-mRNA splicing in a PKA-dependent manner.. | |
Protein Sequence | MAAATIVHDTSEAVELCPAYGLYLKPITKMTISVALPQLKQPGKSISNWEVMERLKGMVQNHQFSTLRISKSTMDFIRFEGEVENKSLVKSFLACLDGKTIKLSGFSDILKVRAAEFKIDFPTRHDWDSFFRDAKDMNETLPGERPDTIHLEGLPCKWFALKESGSEKPSEDVLVKVFEKFGEIRNVDIPMLDPYREEMTGRNFHTFSFGGHLNFEAYVQYREYMGFIQAMSALRGMKLMYKGEDGKAVACNIKVSFDSTKHLSDASIKKRQLERQKLQELEQQREEQKRREKEAEERQRAEERKQKELEELERERKREEKLRKREQKQRDRELRRNQKKLEKLQAEEQKQLQEKIKLEERKLLLAQRNLQSIRLIAELLSRAKAVKLREQEQKEEKLRLQQQEERRRLQEAELRRVEEEKERALGLQRKERELRERLLSILLSKKPDDSHTHDELGVAHADLLQPVLDILQTVSSGCVSATTLHPLGGQPPAGAPKESPAHPEADGAPKSVNGSVAEEAPCKEVQSSCRVVPEDGSPEKRCPGGVLSCIPDNNQQPKGIPACEQNVSRKDTRSEQDKCNREPSKGRGRATGDGLADRHKRERSRARRASSREDGRPRKERRPHKKHAYKDDSPRRRSTSPDHTRSRRSHSKDRHRRERSRERRGSASRKHSRHRRRSERSRSRSPSRHRSTWNR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MAAATIVHDTSE ---CCCCEEEECHHH | 20.85 | 23401153 | |
10 | Phosphorylation | AATIVHDTSEAVELC CCEEEECHHHHHHHC | 17.37 | 23401153 | |
11 | Phosphorylation | ATIVHDTSEAVELCP CEEEECHHHHHHHCH | 29.61 | 23401153 | |
20 | Phosphorylation | AVELCPAYGLYLKPI HHHHCHHHCEECCCC | 7.88 | 23401153 | |
23 | Phosphorylation | LCPAYGLYLKPITKM HCHHHCEECCCCCEE | 14.33 | 23401153 | |
44 | Acetylation | PQLKQPGKSISNWEV HHCCCCCCCCCHHHH | 51.83 | 25953088 | |
44 | Ubiquitination | PQLKQPGKSISNWEV HHCCCCCCCCCHHHH | 51.83 | - | |
86 | Ubiquitination | FEGEVENKSLVKSFL EEEEECCHHHHHHHH | 31.49 | - | |
87 | Phosphorylation | EGEVENKSLVKSFLA EEEECCHHHHHHHHH | 50.40 | - | |
90 | Acetylation | VENKSLVKSFLACLD ECCHHHHHHHHHHHC | 40.56 | 26051181 | |
91 | Phosphorylation | ENKSLVKSFLACLDG CCHHHHHHHHHHHCC | 20.29 | - | |
99 | Acetylation | FLACLDGKTIKLSGF HHHHHCCCEEEECCC | 46.90 | 26051181 | |
99 | 2-Hydroxyisobutyrylation | FLACLDGKTIKLSGF HHHHHCCCEEEECCC | 46.90 | - | |
99 | Ubiquitination | FLACLDGKTIKLSGF HHHHHCCCEEEECCC | 46.90 | - | |
104 | Phosphorylation | DGKTIKLSGFSDILK CCCEEEECCCHHHHH | 32.56 | 23403867 | |
107 | Phosphorylation | TIKLSGFSDILKVRA EEEECCCHHHHHHEE | 27.54 | 23403867 | |
118 | Sumoylation | KVRAAEFKIDFPTRH HHEEEEEECCCCCCC | 32.63 | 25114211 | |
123 | Phosphorylation | EFKIDFPTRHDWDSF EEECCCCCCCCHHHH | 40.40 | 22210691 | |
129 | Phosphorylation | PTRHDWDSFFRDAKD CCCCCHHHHHHCCHH | 23.25 | 24719451 | |
157 | Acetylation | HLEGLPCKWFALKES EECCCCCEEEEEECC | 43.33 | 26051181 | |
162 | Ubiquitination | PCKWFALKESGSEKP CCEEEEEECCCCCCC | 46.54 | - | |
162 | Acetylation | PCKWFALKESGSEKP CCEEEEEECCCCCCC | 46.54 | 26051181 | |
168 | Acetylation | LKESGSEKPSEDVLV EECCCCCCCCHHHHH | 56.38 | 26051181 | |
176 | Acetylation | PSEDVLVKVFEKFGE CCHHHHHHHHHHHCC | 36.73 | 26051181 | |
180 | Acetylation | VLVKVFEKFGEIRNV HHHHHHHHHCCCCCC | 47.40 | 25953088 | |
180 | Ubiquitination | VLVKVFEKFGEIRNV HHHHHHHHHCCCCCC | 47.40 | - | |
218 | Phosphorylation | GHLNFEAYVQYREYM CEECEEHHHHHHHHH | 4.85 | 19053533 | |
221 | Phosphorylation | NFEAYVQYREYMGFI CEEHHHHHHHHHHHH | 8.72 | 19053533 | |
242 | Acetylation | RGMKLMYKGEDGKAV CCCEEEEECCCCCEE | 41.69 | 26051181 | |
317 | Acetylation | EELERERKREEKLRK HHHHHHHHHHHHHHH | 60.45 | 19816843 | |
324 | Acetylation | KREEKLRKREQKQRD HHHHHHHHHHHHHHH | 71.38 | 19816849 | |
339 | Acetylation | RELRRNQKKLEKLQA HHHHHHHHHHHHHHH | 63.98 | 7975553 | |
350 | Ubiquitination | KLQAEEQKQLQEKIK HHHHHHHHHHHHHHH | 57.14 | - | |
381 | Phosphorylation | RLIAELLSRAKAVKL HHHHHHHHHHHHHHH | 42.70 | 24719451 | |
440 | Phosphorylation | ELRERLLSILLSKKP HHHHHHHHHHHCCCC | 18.78 | 20068231 | |
444 | Phosphorylation | RLLSILLSKKPDDSH HHHHHHHCCCCCCCC | 34.88 | 22496350 | |
473 | Phosphorylation | PVLDILQTVSSGCVS HHHHHHHHHHCCCCE | 20.93 | 26074081 | |
475 | Phosphorylation | LDILQTVSSGCVSAT HHHHHHHHCCCCEEE | 25.13 | 26074081 | |
476 | Phosphorylation | DILQTVSSGCVSATT HHHHHHHCCCCEEEE | 31.69 | 26074081 | |
480 | Phosphorylation | TVSSGCVSATTLHPL HHHCCCCEEEEEECC | 24.79 | 26074081 | |
482 | Phosphorylation | SSGCVSATTLHPLGG HCCCCEEEEEECCCC | 23.53 | 26074081 | |
483 | Phosphorylation | SGCVSATTLHPLGGQ CCCCEEEEEECCCCC | 23.84 | 26074081 | |
499 | Phosphorylation | PAGAPKESPAHPEAD CCCCCCCCCCCCCCC | 33.25 | 25849741 | |
510 | Acetylation | PEADGAPKSVNGSVA CCCCCCCCCCCCCHH | 67.51 | 26051181 | |
511 | Phosphorylation | EADGAPKSVNGSVAE CCCCCCCCCCCCHHC | 21.54 | 23403867 | |
515 | Phosphorylation | APKSVNGSVAEEAPC CCCCCCCCHHCCCCC | 16.98 | 23403867 | |
523 | Acetylation | VAEEAPCKEVQSSCR HHCCCCCCCCHHHCE | 60.92 | 26051181 | |
537 | Phosphorylation | RVVPEDGSPEKRCPG EECCCCCCCCCCCCC | 42.05 | 29255136 | |
548 | Phosphorylation | RCPGGVLSCIPDNNQ CCCCCCEECCCCCCC | 13.95 | 18452278 | |
572 | Phosphorylation | QNVSRKDTRSEQDKC CCCCCCCCCCHHHHH | 38.85 | 20068231 | |
574 | O-linked_Glycosylation | VSRKDTRSEQDKCNR CCCCCCCCHHHHHCC | 41.52 | 30379171 | |
574 | Phosphorylation | VSRKDTRSEQDKCNR CCCCCCCCHHHHHCC | 41.52 | 20068231 | |
584 | Phosphorylation | DKCNREPSKGRGRAT HHHCCCCCCCCCCCC | 42.88 | 28985074 | |
591 | Phosphorylation | SKGRGRATGDGLADR CCCCCCCCCCCHHHH | 34.15 | 21815630 | |
598 | Methylation | TGDGLADRHKRERSR CCCCHHHHHHHHHHH | 31.45 | 115916701 | |
610 | Phosphorylation | RSRARRASSREDGRP HHHHHHHHHCCCCCC | 28.28 | 30576142 | |
611 | Phosphorylation | SRARRASSREDGRPR HHHHHHHHCCCCCCC | 38.41 | 30576142 | |
629 | Phosphorylation | RPHKKHAYKDDSPRR CCCCCCCCCCCCCCC | 18.05 | 27174698 | |
633 | Phosphorylation | KHAYKDDSPRRRSTS CCCCCCCCCCCCCCC | 30.36 | 19840947 | |
638 | Phosphorylation | DDSPRRRSTSPDHTR CCCCCCCCCCCCCCH | 31.27 | 20164059 | |
639 | Phosphorylation | DSPRRRSTSPDHTRS CCCCCCCCCCCCCHH | 42.33 | 20363803 | |
640 | Phosphorylation | SPRRRSTSPDHTRSR CCCCCCCCCCCCHHH | 29.58 | 20164059 | |
644 | Phosphorylation | RSTSPDHTRSRRSHS CCCCCCCCHHHCHHC | 37.41 | 30242111 | |
649 | Phosphorylation | DHTRSRRSHSKDRHR CCCHHHCHHCHHHHH | 30.88 | 20068231 | |
651 | Phosphorylation | TRSRRSHSKDRHRRE CHHHCHHCHHHHHHH | 37.18 | 20068231 | |
660 | Phosphorylation | DRHRRERSRERRGSA HHHHHHHHHHHHHHH | 33.47 | 17081983 | |
685 | Phosphorylation | SERSRSRSPSRHRST HHHHHCCCCCCCCCC | 28.59 | 20068231 | |
687 | Phosphorylation | RSRSRSPSRHRSTWN HHHCCCCCCCCCCCC | 41.80 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AK17A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AK17A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AK17A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CC85B_HUMAN | CCDC85B | physical | 16189514 | |
NINL_HUMAN | NINL | physical | 16189514 | |
CACO2_HUMAN | CALCOCO2 | physical | 25416956 | |
THAP1_HUMAN | THAP1 | physical | 25416956 | |
CEP70_HUMAN | CEP70 | physical | 25416956 | |
K1C40_HUMAN | KRT40 | physical | 25416956 | |
JMJD6_HUMAN | JMJD6 | physical | 28514442 | |
ACTN3_HUMAN | ACTN3 | physical | 28514442 | |
KCRM_HUMAN | CKM | physical | 28514442 | |
PININ_HUMAN | PNN | physical | 28514442 | |
MYH7_HUMAN | MYH7 | physical | 28514442 | |
MYH4_HUMAN | MYH4 | physical | 28514442 | |
ANR17_HUMAN | ANKRD17 | physical | 28514442 | |
UBE2O_HUMAN | UBE2O | physical | 28514442 | |
ANKH1_HUMAN | ANKHD1 | physical | 28514442 | |
CAAP1_HUMAN | CAAP1 | physical | 28514442 | |
HAUS4_HUMAN | HAUS4 | physical | 28514442 | |
CAPON_HUMAN | NOS1AP | physical | 28514442 | |
SRRM2_HUMAN | SRRM2 | physical | 28514442 | |
CSK21_HUMAN | CSNK2A1 | physical | 28514442 | |
NKAP_HUMAN | NKAP | physical | 28514442 | |
TRPM3_HUMAN | TRPM3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-537, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-537, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-537 AND SER-633, ANDMASS SPECTROMETRY. |